CBD Nanoemulsion Reduced Both Anxiety and Panic Responses in Rats at Lower Doses

What the researchers found

Chronic oral CBD nanoemulsion (2.5 mg/kg for 21 days) produced anxiolytic and panicolytic effects in rats tested on the elevated T-maze. The effects were linked to increased activity in serotonin-producing neurons of the dorsal raphe nucleus. Acute CBD showed no behavioral effects. Brain tissue analysis confirmed CBD reached the brain at measurable concentrations.

Why it matters

CBD's poor oral bioavailability has been a major barrier to clinical use. Nanoemulsion formulations can improve absorption, potentially allowing lower effective doses. This study shows a nanoemulsion CBD formulation produced anti-anxiety and anti-panic effects at relatively low doses in rats.

The numbers in context

CBD 2.5 mg/kg yielded 64.25 ng CBD/g brain tissue; CBD 5.0 mg/kg yielded 21.22 ng/g. Only the 2.5 mg/kg dose showed behavioral effects. 21 days of chronic treatment needed.

How the study worked

Male Wistar rats received oral CBD nanoemulsion (2.5 or 5 mg/kg) or vehicle daily for 21 days. Behavioral testing used the elevated T-maze. Brain CBD levels were measured. Immunohistochemistry examined FosB/deltaFosB expression and tryptophan hydroxylase in the dorsal raphe and periaqueductal gray.

What this study cannot tell us

Animal study in male rats only. Only two doses tested. Inverted dose-response needs further investigation. Nanoemulsion formulation may not translate directly to human use.

How to read the evidence

Preliminary: animal study with novel formulation, detailed mechanistic work but no human data.

When this study was published

Published in 2025.

The bigger picture

The finding that a lower dose (2.5 mg/kg) was more effective than a higher dose (5.0 mg/kg) aligns with CBD's known biphasic dose-response pattern. The nanoemulsion delivery format could improve clinical translation.

Questions still open

• Why was the lower CBD dose more effective than the higher dose?
• Would CBD nanoemulsions show similar anti-anxiety effects in humans?
• Could this formulation approach reduce the high CBD doses typically needed for clinical effects?

Common questions

Read the original research

A cannabidiol (CBD) lipid-based nanoemulsion induces anxiolytic- and panicolytic-like effects and increases FosB/deltaFosB immunoreactivity in serotonergic cells of the dorsal raphe.

Brain research, 1864, 149791

Citation

Rosário, Bárbara A; de Lima, Maria Paula; Vieira, Márcio G; Leite, Laís Garret; de Aquino, Pedro E A; Viana, Glauce S B; Silveira, Edilberto R; de Brito, Débora H A; Zampieri, Dávila; Ricardo, Nágila Maria P S; Lemes, Jéssica A; Tucci, Adriana M; Ribeiro, Daniel A; Viana, Milena B. (2025). A cannabidiol (CBD) lipid-based nanoemulsion induces anxiolytic- and panicolytic-like effects and increases FosB/deltaFosB immunoreactivity in serotonergic cells of the dorsal raphe.. Brain research, 1864, 149791. https://doi.org/10.1016/j.brainres.2025.149791

Explore the wider topic

• CBD Oil Quality Guide: How to Avoid Snake Oil
• Anxiety After Quitting Weed: When to Consider Medication
• Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
• Cannabis for Chronic Pain: What the Research Actually Supports
• Cannabis and Epilepsy: The Epidiolex Story and What It Means
• Does CBD Actually Work for Anxiety? What the Evidence Shows
• Does CBD Help with Weed Withdrawal? What Studies Show
• CBD vs THC: The Differences That Actually Matter
• The Proven Medical Benefits of Cannabis: What Research Supports
• Quitting Weed Before Surgery
• Weed and Medications: What Changes When You Quit
• Quitting Weed During Pregnancy: What You Need to Know
• Quitting Weed While Pregnant: What You Need to Know
• Cannabis and Older Adults: Risks Seniors Should Know
• Cannabis and Breastfeeding: THC in Breast Milk